Max Robotics — Global Service Robot Directory + US Certification

About

Shinichi Terada is a leading gynecologic oncologist whose research focuses on refining surgical approaches for early-stage cervical and endometrial cancers. His most impactful work critically evaluates the oncologic safety of minimally invasive surgery (MIS) versus traditional abdominal radical hysterectomy (ARH). In his highly cited 2022 study, Terada demonstrated that MIS may be associated with higher recurrence and mortality rates in early-stage cervical cancer patients compared to ARH—a finding that has influenced surgical decision-making worldwide. He has also pioneered innovative techniques in robot-assisted surgery, notably developing a modified radical hysterectomy that uses indocyanine green (ICG) for sentinel lymph node mapping and lymphatic vessel removal, enhancing precision and safety. His 2024 investigation into sentinel lymph node biopsy outcomes further advances understanding of nodal staging in cervical cancer. With over a decade of cumulative citations, Terada’s work bridges the gap between technological advancement and patient survival, establishing him as a key voice in the ongoing debate over the optimal surgical management of gynecologic malignancies.